BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9430187)

  • 1. Baseline institutional compliance with NCCN guidelines: non-small-cell lung cancer.
    Walsh GL; Winn RJ
    Oncology (Williston Park); 1997 Nov; 11(11A):161-70. PubMed ID: 9430187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Surgery in non-small cell lung cancer of the superior sulcus: results of a combined preoperative and postoperative irradiation regime].
    Pfannschmidt J; Muley T; Hoffmann H; Dienemann H
    Zentralbl Chir; 2004 Aug; 129(4):270-5. PubMed ID: 15354247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A breast center review of compliance with National Comprehensive Cancer Network Breast Cancer guidelines.
    Landercasper J; Dietrich LL; Johnson JM
    Am J Surg; 2006 Oct; 192(4):525-7. PubMed ID: 16978966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reported management of lung cancer in Victoria in 1993: comparison with best practice. Anti-Cancer Council of Victoria Lung Cancer Study Group.
    Richardson GE; Thursfield VJ; Giles GG
    Med J Aust; 2000 Apr; 172(7):321-4. PubMed ID: 10844918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Institutional validation of breast cancer treatment guidelines.
    Minter RM; Spengler KK; Topping DP; Flug R; Copeland EM; Lind DS
    J Surg Res; 2001 Sep; 100(1):106-9. PubMed ID: 11516212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Practice of perioperative chemotherapy for non small cell lung cancer].
    Westeel V
    Rev Mal Respir; 2007 Oct; 24(8 Pt 2):6S69-72. PubMed ID: 18235397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ["Intentionally" limited pulmonary resection versus lobectomy for the treatment of peripheral stage IA non-small cell lung cancers].
    Mondello B; Sibilio M; Pavone A; Monaco F; Nunnari F; Micali V; Vasta I; Perrone O; Monaco M
    G Chir; 2007; 28(1-2):7-12. PubMed ID: 17313726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse outcomes associated with noncompliance with melanoma treatment guidelines.
    Erickson Foster J; Velasco JM; Hieken TJ
    Ann Surg Oncol; 2008 Sep; 15(9):2395-402. PubMed ID: 18600380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung function evaluation before surgery in lung cancer patients: how are recent advances put into practice? A survey among members of the European Society of Thoracic Surgeons (ESTS) and of the Thoracic Oncology Section of the European Respiratory Society (ERS).
    Charloux A; Brunelli A; Bolliger CT; Rocco G; Sculier JP; Varela G; Licker M; Ferguson MK; Faivre-Finn C; Huber RM; Clini EM; Win T; De Ruysscher D; Goldman L;
    Interact Cardiovasc Thorac Surg; 2009 Dec; 9(6):925-31. PubMed ID: 19752152
    [No Abstract]   [Full Text] [Related]  

  • 10. Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer.
    Meyers BF; Haddad F; Siegel BA; Zoole JB; Battafarano RJ; Veeramachaneni N; Cooper JD; Patterson GA
    J Thorac Cardiovasc Surg; 2006 Apr; 131(4):822-9; discussion 822-9. PubMed ID: 16580440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sublobar resections in stage IA non-small cell lung cancer: segmentectomies result in significantly better cancer-related survival than wedge resections.
    Sienel W; Dango S; Kirschbaum A; Cucuruz B; Hörth W; Stremmel C; Passlick B
    Eur J Cardiothorac Surg; 2008 Apr; 33(4):728-34. PubMed ID: 18261918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in the pattern of care for lung cancer and their correlation with new clinical evidence: experiences in a university-affiliated medical center.
    Chien CR; Lai MS
    Am J Med Qual; 2006; 21(6):408-14. PubMed ID: 17077423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgery after multimodality treatment for non-small-cell lung cancer.
    Stamatis G; Eberhard W; Pöttgen C
    Lung Cancer; 2004 Aug; 45 Suppl 2():S107-12. PubMed ID: 15552790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinician agreement with perioperative cardiovascular evaluation guidelines and clinical outcomes.
    Legner VJ; Doerner D; McCormick WC; Reilly DF
    Am J Cardiol; 2006 Jan; 97(1):118-22. PubMed ID: 16377295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Follow-up after melanoma resection is more extensive than recommended in the practice guidelines, primarily for reassurance of the patient].
    Mijnhout GS; Teule GJ; Hoekstra OS; Pijpers R; Borgstein PJ; Meijer S
    Ned Tijdschr Geneeskd; 1999 May; 143(19):997-1001. PubMed ID: 10368721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
    Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of multidisciplinary lung cancer practice.
    Conron M; Phuah S; Steinfort D; Dabscheck E; Wright G; Hart D
    Intern Med J; 2007 Jan; 37(1):18-25. PubMed ID: 17199840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future of adjuvant chemotherapy for resected non-small cell lung cancer.
    Vansteenkiste JF; Schildermans RH
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):165-75. PubMed ID: 15757448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of surgical resection for nonsmall cell lung cancer in a US metropolitan area.
    Allen JW; Farooq A; O'Brien TF; Osarogiagbon RU
    Cancer; 2011 Jan; 117(1):134-42. PubMed ID: 20737568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in patients with ipsilateral pulmonary metastasis from non-small cell lung cancer.
    Nakagawa T; Okumura N; Miyoshi K; Matsuoka T; Kameyama K
    Eur J Cardiothorac Surg; 2005 Oct; 28(4):635-9. PubMed ID: 16126398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.